orforglipron

1 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Nov 11, 2025 by Dave Ricks · across every show →

Everything said about orforglipron, oldest first

Nov 11, 2025 positive
Assertion Supported
Ricks: Tirzepatide's US patent extends into the late 2030s
“I think Terseptide's U.S. Patent is late thirties or foregrip on the oral beyond that.”
Dave Ricks Nov 11, 2025 ▶ 1:49:39 Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Made with StarZero

Turn any episode into a week of clips.

This entire site, about 28 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.